Clinical significance of macrophage colony stimulating factor levels in acute coronary syndrome

Minerva Cardioangiologica

Volumn 57, Issue 1, 2009, Pages 7-11

  Novo, G ^a   Assennato, P ^a   Caruso, M ^a   Turturici, C ^a   Balistreri, C R ^a   Amoroso, G R ^a   Fazio, G ^a   Rotolo, A ^a   Coppola, G ^a   Hoffmann, E ^a   Caruso, C ^a   Novo, S ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Acute coronary syndrome; Macrophage colony stimulating factor; Ventricular dysfunction, left

Indexed keywords

C REACTIVE PROTEIN; COLONY STIMULATING FACTOR 1; FIBRINOGEN; LIPID; TROPONIN I; BIOLOGICAL MARKER;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD SAMPLING; CORONARY ARTERY DISEASE; CORONARY CARE UNIT; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; FIBRINOGEN BLOOD LEVEL; HEART REINFARCTION; HOSPITALIZATION; HUMAN; ITALY; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT; PROTEIN BLOOD LEVEL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; UNIVERSITY HOSPITAL; BLOOD; ELECTROCARDIOGRAPHY; EMERGENCY TREATMENT; HEART INFARCTION; METABOLISM; MIDDLE AGED; PREDICTION AND FORECASTING; PROGNOSIS;

ACUTE CORONARY SYNDROME; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; ELECTROCARDIOGRAPHY; EMERGENCY TREATMENT; FEMALE; FIBRINOGEN; HUMANS; LIPIDS; MACROPHAGE COLONY-STIMULATING FACTOR; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TROPONIN I;

EID: 67849118858     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 2001;104:365. (Pubitemid 32666962)
2. Biasucci LM, Liuzzo G, Grillon RT, Caligiuri G, Rebuzzi AG, Buffon A et al. Elevated C reactive protein at discharge in patients with unstable angina predicts recurrent instability. Circulation 1999;99:855-60. (Pubitemid 29094296)
3. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centres for Disease Control and Prevention and the American Heart Association. Circulation 2003;107:499-511. (Pubitemid 36158056)
4. Novo S, Basili S, Tantillo R, Falco A, Davì V, Novo G et al. Soluble CD40L and cardiovascular risk in asymptomatic low-grade carotid stenosis. Stroke 2005;36:673-5.
5. Ferroni P, Novo S, Davi V, Novo G, Basili S, Davì G. Circulating transforming growth factor-beta1 levels in asymptomatic carotid plaques. Stroke 2005;36:525-6.
6. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002;05:1135-43.
7. Moreno PR, Falk E, Palacios IF, Newell JB, Fuster V, Fallon JT. Macrophage infiltration in acute coronary syndromes: implications in plaque rupture. Circulation 1994;90:775-8. (Pubitemid 24242744)
8. Roth P, Stanley ER. The biology of CSF-1 and its receptor. Curr Top Microbiol Immunol 1992;181:141-67.
9. Scheldt S, Wilner G, Fillmore S, Shapiro M, Killip T Objective haemodynamic assessment after acute myocardial infarction. Br Heart J 1973;35:908-16.
10. Grundy SM, Cleeman JI, Bairey Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB et al. Implications of recent clinical trials for the national cholesterol education program. Adult Treatment Panel III Guidelines. Circulation 2004;110:227-39.
11. Stamm RB, Carabello PA, Mayers DL, Martin RP. Two-dimensional echocardiographic measurement of left ventricular ejection fraction: prospective analysis of what constitutes an adeguate determination. Am Heart J 1982;104:136.
12. Silber S, Albertsson P, Avilès FF, Camici PG, Colombo A, Hamm C et al. Guidelines for percutaneous coronary intervention. The task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J 2005;26:804-47.
13. Stadius ML, Alderman EL. Coronary artery revascularization-critical need for and consequences of objective angiographic assessment of lesion severity. Circulation 1990;82:2231.
14. Coppola G, Corrado E, Muratori I, Tantillo R, Vitale G, Lo Coco L et al. Increased levels of C-reactive protein and fibrinogen influence the risk of vascular events in patients with NIDDM. Int J Cardiol 2006;106:16-20. (Pubitemid 41728904)
15. Lendon CL, Davies MJ, Born GV, Richardson PD. Atherosclerotic plaque caps are locally weakened when macrophage density is increased. Atherosclerosis 1991;87:87-90.
16. Ikonomidis I, Lekakis J, Revela I, Andreotti F, Nihoyannopoulos P. Increased circulating C reactive protein and macrophage colony stimulating factor are complementary predictors of long term outcome in patients with chronic coronary artery disease. Eur Heart J 2005;26:1618-24. (Pubitemid 41389692)
17. Hoyo Y, Ikeda U, Takahashi M, Shimada K. Increased levels of monocyte derived cytokine in patients with unstable angina. Atherosclerosis 2002;161:403-8. (Pubitemid 34219194)
18. Rallidis LS, Thomaidis KP, Zolindaki MG, Velissaridou AH, Papasteriadis EG. Elevated concentrations of macrophage colony stimulating factor predict worse in hospital prognosis in unstable angina. Heart 2001;86:92.
19. Rallidis LS, Zolindaki MG, Manioudaki HS, Laoutaris NP, Velissaridou AH, Papasteriadis EG. Prognostic value of C-reactive protein, fibrinogen, interleukin 6 and macrophage colony stimulating factor in severe unstable angina. Clin Cardiol 2002;25:505-10.
20. Rallidis LS, Zolindaki MG, Pentzeridis PC, Poulopoulos KP, Velissaridou AH, Apostolou TS. Raised concentration of macrophage colony stimulating factor in severe unstable angina beyond the acute phase are strongly predictive of long term outcome. Heart 2004;90:25-9.
21. Saitoh T, Kishida H, Tsukada Y, Fukuma Y, Sano J, Yasutake M et al. Clinical significance of increased concentration of macrophage colony stimulating factor in patients with angina pectoris. J Am Coll Cardiol 2000;35:655-65. (Pubitemid 30167022)
22. Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation 2003;108:1664-72.
23. Postiglione L, Montagnani S, Ladogana P, Castaldo C, Di Spigna G, Bruno EM et al. Granulocyte Macrophage-Colony Stimulating Factor receptor expression on human cardiomyocytes from end-stage heart failure patients. Eur J Heart Fail 2006;8:564-70.
24. Maekawa Y, Anzai T, Yoshikawa T, Sugano Y, Mahara K, Kohno T et al. Effect of granulocyte-macrophage colony stimulating factor inducer on left ventricular remodelling after acute myocardial infarction. J Am Coll Cardiol 2004;44:1510-20.